Literature DB >> 14567520

Ribavirin in the treatment of severe acute respiratory syndrome (SARS).

M G A van Vonderen1, J C Bos, J M Prins, P Wertheim-van Dillen, P Speelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14567520

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


× No keyword cloud information.
  13 in total

1.  Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.

Authors:  Adeyemi O Adedeji; William Severson; Colleen Jonsson; Kamalendra Singh; Susan R Weiss; Stefan G Sarafianos
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

2.  Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells.

Authors:  Ling Yi; Zhengquan Li; Kehu Yuan; Xiuxia Qu; Jian Chen; Guangwen Wang; Hong Zhang; Hongpeng Luo; Lili Zhu; Pengfei Jiang; Lirong Chen; Yan Shen; Min Luo; Guoying Zuo; Jianhe Hu; Deliang Duan; Yuchun Nie; Xuanling Shi; Wei Wang; Yang Han; Taisheng Li; Yuqing Liu; Mingxiao Ding; Hongkui Deng; Xiaojie Xu
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

3.  SARS patients and need for treatment.

Authors:  Johnny W M Chan; Samuel Lee
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

Review 4.  Treatment of severe acute respiratory syndrome.

Authors:  S T Lai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 5.  Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.

Authors:  C W Leung; W K Chiu
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

6.  Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Scott Winslow; Justin Hoopes; Joseph K-K Li; Jongdae Lee; Dennis A Carson; Howard B Cottam; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-03-24       Impact factor: 5.970

Review 7.  Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection.

Authors:  Manashjyoti Konwar; Diganta Sarma
Journal:  Tetrahedron       Date:  2020-11-19       Impact factor: 2.457

8.  Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies.

Authors:  Yi-Ting Fang; Chiou-Feng Lin; Pao-Chi Liao; Yu-Min Kuo; Shuying Wang; Trai-Ming Yeh; Chi-Chang K Shieh; Ih-Jen Su; Huan-Yao Lei; Yee-Shin Lin
Journal:  Mol Immunol       Date:  2009-12-16       Impact factor: 4.407

Review 9.  Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

Authors:  Tommy R Tong
Journal:  Perspect Med Virol       Date:  2006-11-28

Review 10.  Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak.

Authors:  Anamika Pandey; Mohd Kamran Khan; Mehmet Hamurcu; Sait Gezgin
Journal:  Front Plant Sci       Date:  2020-10-15       Impact factor: 5.753
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.